Amylyx Pharmaceuticals, Inc. (AMLX) Revenue 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2025 · since FY2021: $285,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $87.4M | -77.1% |
| FY2023 | $380.8M | +1612.9% |
| FY2022 | $22.2M | +7700.0% |
| FY2021 | $285,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice